Advances in immunotherapy have led to durable and long‐term benefits in a subset of
patients across a number of solid tumor types. Understanding of the subsets of patients that …

Objectives Thrombotic and microvascular complications are frequently seen in deceased
COVID‐19 patients. However, whether this is caused by direct viral infection of the endothelium …

Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which
emerged in late 2019 has spread globally, causing a pandemic of respiratory illness designated …

Mucosal head and neck squamous cell carcinoma (HNSCC) are the seventh most common
cancer, with approximately 50% of patients living beyond 5 years. Immune checkpoint …

Purpose Robust biomarkers that predict disease outcomes amongst COVID-19 patients are
necessary for both patient triage and resource prioritisation. Numerous candidate …

The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is known to present
with pulmonary and extra‐pulmonary organ complications. In comparison with the 2009 …

The concept of epithelial–mesenchymal plasticity (EMP), which describes the dynamic flux
within the spectrum of phenotypic states that invasive carcinoma cells may reside, is being …

Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that has
few effective treatment options due to its lack of targetable hormone receptors. Whilst the …

The composition and activation status of the cellular milieu contained within the tumour
microenvironment (TME) is becoming increasingly recognized as a driving factor for …

Dynamic interconversions between transitional epithelial and mesenchymal states underpin
the epithelial mesenchymal plasticity (EMP) seen in some carcinoma cell systems. We have …